{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:41:17Z","timestamp":1789897277253,"version":"4.0.1"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ mailto:journals.permissions@oup.com"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosurg.","NEUROS"],"published-print":{"date-parts":[[2020,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>Primary intratumoral hemorrhage as a presenting sign is rare in children with medulloblastomas but may result in severe complications. Given the distinct properties of molecular medulloblastoma subgroups, the impact on neurosurgical practice has still to be defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To investigate both clinical and radiological presentation of intratumoral hemorrhage in medulloblastoma patients in the context of molecular subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>\n                      Data of all consecutive medulloblastoma patients treated at our institution between 1993 and 2018 (n\u00a0=\u00a0104) were retrospectively reviewed in respect of clinical and radiological presentation as well as molecular subgroups. For cases with available tumor tissue (n\u00a0=\u00a086), subgroups were assigned by either 450 K methylation array or immunohistochemistry and\n                      <jats:italic toggle=\"yes\">CTNNB1<\/jats:italic>\n                      sequencing. Available imaging at diagnosis (n\u00a0=\u00a062) was reviewed by an experienced neuroradiologist.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Within the entire cohort, 4 patients (4%) presented with massive spontaneous hemorrhage. Although no patient died as a direct consequence of hemorrhage, all suffered from serious sequelae. Moreover, 3 additional patients displayed radiological evidence of significant hemorrhage. Interestingly, all 7 cases belonged to the wingless (WNT) subgroup (n\u00a0=\u00a013), resulting in intratumoral hemorrhage in 54% (7\/13) of pediatric WNT medulloblastomas. In contrast, significant hemorrhage was absent in all other molecular subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION<\/jats:title>\n                    <jats:p>Our results suggest that a substantial proportion of pediatric WNT medulloblastomas display significant intratumoral hemorrhage at the time of diagnosis. Consequently, the presence of significant hemorrhage in fourth ventricle childhood tumors is suggestive of WNT medulloblastoma and should lead to a less aggressive attempt for total resection in this prognostically favorable tumor type.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuros\/nyz148","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T23:11:49Z","timestamp":1555715509000},"page":"478-484","source":"Crossref","is-referenced-by-count":9,"title":["Predisposition of Wingless Subgroup Medulloblastoma for Primary Tumor Hemorrhage"],"prefix":"10.1227","volume":"86","author":[{"given":"Dominik","family":"Reisinger","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Gojo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Kasprian","sequence":"additional","affiliation":[{"name":"Department of Radiology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Haberler","sequence":"additional","affiliation":[{"name":"Institute of Neurology, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Peyrl","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo A","family":"Azizi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Mayr","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Chocholous","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Kool","sequence":"additional","affiliation":[{"name":"Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany"},{"name":"Division of Pediatric Neuro-Oncology, German Cancer Research Center DKFZ, Heidelberg, Germany"},{"name":"German Cancer Consortium DKTK, Heidelberg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8112-2795","authenticated-orcid":false,"given":"Thomas","family":"Czech","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Slavc","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,4]]},"reference":[{"issue":"suppl_10","key":"bib1-20231011","doi-asserted-by":"crossref","first-page":"x1","DOI":"10.1093\/neuonc\/nou327","article-title":"Alex's Lemonade stand foundation infant and childhood primary brain and central nervous system tumors diagnosed in the united states in 2007\u20132011","volume":"16","author":"Ostrom","year":"2015","journal-title":"Neuro Oncol"},{"issue":"10","key":"bib2-20231011","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","article-title":"Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial","volume":"7","author":"Gajjar","year":"2006","journal-title":"Lancet Oncol"},{"issue":"5","key":"bib3-20231011","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11910-016-0644-7","article-title":"Medulloblastoma: tumor biology and relevance to treatment and prognosis paradigm","volume":"16","author":"Coluccia","year":"2016","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"12","key":"bib4-20231011","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1200\/JCO.2005.04.4974","article-title":"Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations","volume":"24","author":"Thompson","year":"2006","journal-title":"J Clin Oncol"},{"issue":"8","key":"bib5-20231011","doi-asserted-by":"crossref","first-page":"e3088","DOI":"10.1371\/journal.pone.0003088","article-title":"Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features","volume":"3","author":"Kool","year":"2008","journal-title":"PLoS One"},{"issue":"11","key":"bib6-20231011","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1200\/JCO.2009.27.4324","article-title":"Medulloblastoma comprises four distinct molecular variants","volume":"29","author":"Northcott","year":"2011","journal-title":"J Clin Oncol"},{"issue":"11","key":"bib7-20231011","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1200\/JCO.2010.28.5148","article-title":"Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome","volume":"29","author":"Cho","year":"2011","journal-title":"J Clin Oncol"},{"issue":"29","key":"bib8-20231011","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1200\/JCO.2011.36.2798","article-title":"FSTL5 is a marker of poor prognosis in non-WNT\/non-SHH medulloblastoma","volume":"29","author":"Remke","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"bib9-20231011","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00401-016-1569-6","article-title":"Risk stratification of childhood medulloblastoma in the molecular era: the current consensus","volume":"131","author":"Ramaswamy","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"7","key":"bib10-20231011","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S1470-2045(17)30243-7","article-title":"Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study","volume":"18","author":"Schwalbe","year":"2017","journal-title":"Lancet Oncol"},{"issue":"7663","key":"bib11-20231011","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature22973","article-title":"The whole-genome landscape of medulloblastoma subtypes","volume":"547","author":"Northcott","year":"2017","journal-title":"Nature"},{"issue":"6","key":"bib12-20231011","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ccell.2017.05.005","article-title":"Intertumoral Heterogeneity within Medulloblastoma Subgroups","volume":"31","author":"Cavalli","year":"2017","journal-title":"Cancer Cell"},{"issue":"31","key":"bib13-20231011","doi-asserted-by":"crossref","first-page":"7951","DOI":"10.1200\/JCO.2005.01.5479","article-title":"\u03b2-catenin status predicts a favorable outcome in childhood medulloblastoma: The United Kingdom Children's Cancer Study Group Brain Tumour Committee","volume":"23","author":"Ellison","year":"2005","journal-title":"J Clin Oncol"},{"issue":"7035","key":"bib14-20231011","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature03319","article-title":"Wnt signalling in stem cells and cancer","volume":"434","author":"Reya","year":"2005","journal-title":"Nature"},{"issue":"3","key":"bib15-20231011","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ijc.1342","article-title":"Somatic mutations of WNT\/wingless signaling pathway components in primitive neuroectodermal tumors","volume":"93","author":"Koch","year":"2001","journal-title":"Int J Cancer"},{"issue":"22","key":"bib16-20231011","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.4161\/cc.5.22.3446","article-title":"Wnt\/Wingless pathway activation and chromosome 6 loss characterise a distinct molecular sub-group of medulloblastomas associated with a favourable prognosis","volume":"5","author":"Clifford","year":"2006","journal-title":"Cell Cycle"},{"issue":"7327","key":"bib17-20231011","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nature09587","article-title":"Subtypes of medulloblastoma have distinct developmental origins","volume":"468","author":"Gibson","year":"2010","journal-title":"Nature"},{"key":"bib18-20231011","year":"2018"},{"issue":"7","key":"bib19-20231011","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1002\/pbc.25002","article-title":"Duration of the pre-diagnostic interval in medulloblastoma is subgroup dependent","volume":"61","author":"Ramaswamy","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"bib20-20231011","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.ccell.2016.03.002","article-title":"Medulloblastoma genotype dictates blood brain barrier phenotype","volume":"29","author":"Phoenix","year":"2016","journal-title":"Cancer Cell"},{"issue":"12","key":"bib21-20231011","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.3174\/ajnr.A4495","article-title":"MR imaging characteristics of wingless-type-subgroup pediatric medulloblastoma","volume":"36","author":"Patay","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"issue":"6","key":"bib22-20231011","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00401-013-1126-5","article-title":"Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays","volume":"125","author":"Hovestadt","year":"2013","journal-title":"Acta Neuropathol"},{"issue":"5","key":"bib23-20231011","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/088307380001500503","article-title":"Nontraumatic brain hemorrhage in children: etiology and presentation","volume":"15","author":"Al-Jarallah","year":"2000","journal-title":"J Child Neurol"},{"issue":"3","key":"bib24-20231011","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4103\/1817-1745.165727","article-title":"Fatal cerebellar hemorrhage as an initial presentation of medulloblastoma in a child","volume":"10","author":"Menekse","year":"2015","journal-title":"J Pediatr Neurosci"},{"issue":"7","key":"bib25-20231011","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1007\/s00381-006-0290-5","article-title":"Undiagnosed medulloblastoma presenting as fatal hemorrhage in a 14-year-old boy: case report and review of the literature","volume":"23","author":"Santi","year":"2007","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"bib26-20231011","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3171\/jns.1983.58.4.0543","article-title":"Medulloblastoma: clinical presentation and management","volume":"58","author":"Park","year":"1983","journal-title":"J Neurosurg"},{"issue":"mar29 1","key":"bib27-20231011","first-page":"bcr1020092378","article-title":"Sudden death due to medulloblastoma","volume":"2010","author":"Vyshka","year":"2010","journal-title":"Case Rep"},{"issue":"4","key":"bib28-20231011","first-page":"263","article-title":"Hemorrhagic brain tumors in pediatric patients","volume":"8","author":"Laurent","year":"1981","journal-title":"Childs Brain"},{"issue":"5905","key":"bib29-20231011","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1126\/science.1164594","article-title":"Canonical wnt signaling regulates organ-specific assembly and differentiation of cns vasculature","volume":"322","author":"Stenman","year":"2008","journal-title":"Science"},{"issue":"1","key":"bib30-20231011","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12883-016-0632-1","article-title":"Anomalous vascularization in a Wnt medulloblastoma: a case report","volume":"16","author":"Di Giannatale","year":"2016","journal-title":"BMC Neurol"},{"issue":"6","key":"bib31-20231011","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3171\/2014.8.PEDS13590","article-title":"A patient with medulloblastoma in its early developmental stage","volume":"14","author":"Shinojima","year":"2014","journal-title":"J Neurosurg Pediatr"},{"issue":"7","key":"bib32-20231011","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3174\/ajnr.A3990","article-title":"MRI surrogates for molecular subgroups of medulloblastoma","volume":"35","author":"Perreault","year":"2014","journal-title":"AJNR Am J Neuroradiol"},{"issue":"10","key":"bib33-20231011","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3174\/ajnr.A5313","article-title":"Imaging biomarkers for adult medulloblastomas: genetic entities may be identified by their MR imaging radiophenotype","volume":"38","author":"Keil","year":"2017","journal-title":"AJNR Am J Neuroradiol"},{"issue":"4","key":"bib34-20231011","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S1470-2045(15)00581-1","article-title":"Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis","volume":"17","author":"Thompson","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/neurosurgery\/advance-article-pdf\/doi\/10.1093\/neuros\/nyz148\/28566732\/nyz148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyz148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:45:46Z","timestamp":1786121146000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1093\/neuros\/nyz148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1093\/neuros\/nyz148","relation":{},"ISSN":["0148-396X","1524-4040"],"issn-type":[{"value":"0148-396X","type":"print"},{"value":"1524-4040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]}}}